These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9790789

  • 1. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I, Nanbu K, Mandai M, Tsuruta Y, Kataoka N, Nagata Y, Mori T.
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [Abstract] [Full Text] [Related]

  • 2. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma.
    Fujiwaki R, Takahashi K, Kitao M.
    Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ.
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Chen H, Liang C, Zhang L, Huang S, Wu X.
    Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.
    Harpole DH, Moore MB, Herndon JE, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I, Allegra C.
    Clin Cancer Res; 2001 Mar; 7(3):562-9. PubMed ID: 11297249
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
    Guo GF, Xie RH, Yang AK, Chen ZH, Wu QL, Liu WW, Ou SM, Xia LP, Chen MY, Zhang JX.
    Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.
    J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
    [Abstract] [Full Text] [Related]

  • 9. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
    Chen CL, Sheen TS, Lou IU, Huang AC.
    Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
    [Abstract] [Full Text] [Related]

  • 10. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S, Terzano P, Bovicelli A, Martoni A, Angelelli B, Santini D, Ceccarelli C, Lipponen P, Erzén M, Syrjänen S, Syrjänen K.
    Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J, Tan PH, Thiyagarajan J, Bay BH.
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
    Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    BMC Cancer; 2008 Oct 11; 8():295. PubMed ID: 18847499
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
    Lai CH, Hsueh S, Chang TC, Tseng CJ, Huang KG, Chou HH, Chen SM, Chang MF, Shum HC.
    Gynecol Oncol; 1997 Mar 11; 64(3):456-62. PubMed ID: 9062150
    [Abstract] [Full Text] [Related]

  • 14. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
    Vural E, Alexiou M, Hunt J, Korourian S, Hanna E.
    Am J Otolaryngol; 2001 Mar 11; 22(4):257-60. PubMed ID: 11464322
    [Abstract] [Full Text] [Related]

  • 15. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 11; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K.
    Gynecol Oncol; 2001 Jun 11; 81(3):496-9. PubMed ID: 11371145
    [Abstract] [Full Text] [Related]

  • 17. XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.
    Kim K, Kang SB, Chung HH, Kim JW, Park NH, Song YS.
    Gynecol Oncol; 2008 Dec 11; 111(3):509-15. PubMed ID: 18851872
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N.
    Cancer; 1996 Aug 01; 78(3):416-21. PubMed ID: 8697385
    [Abstract] [Full Text] [Related]

  • 19. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y.
    Cancer; 2009 Jul 15; 115(14):3324-34. PubMed ID: 19452547
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
    Yamakawa Y, Fujimura M, Hidaka T, Hori S, Saito S.
    Gynecol Oncol; 2000 May 15; 77(2):264-70. PubMed ID: 10785476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.